• head_banner_01

2022 High quality Basic Amino Acids Are - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We are also focusing on improving the stuff management and QC system so that we could keep great advantage in the fiercely-competitive business for Succinylcholine Chloride, 4-Methoxybenzylamine, 1 2-Dimethyl-1h-Imidazole, We warmly welcome mates from all walks of life to hunt mutual cooperation and develop a more good and splendid tomorrow.
2022 High quality Basic Amino Acids Are - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

2022 High quality Basic Amino Acids Are - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

2022 High quality Basic Amino Acids Are - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

To create more value for customers is our business philosophy; customer growing is our working chase for 2022 High quality Basic Amino Acids Are - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Irish, Armenia, Angola, We hope we can establish long-term cooperation with all of the customers, and hope we can improve competitiveness and achieve the win-win situation together with the customers. We sincerely welcome the customers from all over the world to contact us for anything you need to have!Welcome all customers both at home and abroad to visit our factory. We hope to have win-win business relationships with you, and create a better tomorrow.
  • Hope that the company could stick to the enterprise spirit of "Quality, Efficiency, Innovation and Integrity", it will be better and better in the future.
    5 Stars By Marjorie from Birmingham - 2017.09.22 11:32
    Product quality is good, quality assurance system is complete, every link can inquire and solve the problem timely!
    5 Stars By Lynn from Turkmenistan - 2018.11.22 12:28
    Write your message here and send it to us